Literature DB >> 29934220

Factors associated with optimal pain management in advanced cancer patients.

Nanya Wang1, Yabing Dong1, Lingling Zhao1, Hengjun Zhao1, Wei Li1, Jiuwei Cui2.   

Abstract

PURPOSE: To analyze clinical factors that were associated with inadequate pain control in cancer patients with metastatic malignancy and moderate to severe baseline pain. PATIENTS: We retrospectively analyzed data from 260 advanced cancer patients who admitted to the First Hospital of Jilin University (Jilin, China) from January 2012-May 2013. MEASUREMENTS: Statistical analysis was performed to assess the correlation between pain control and baseline characteristics including, gender, patient age, type of malignancy, presence of bone metastases, pain intensity, pain location, etiology of pain, type of pain, and presence of breakthrough pain. MAIN
RESULTS: A total of 75.4% of patients obtained satisfactory pain control (numerical rating scale ≤ 3) in 3 days. Baseline characteristics including gastrointestinal tumors (P = 0.032), severe pain (P < 0.001), and frequent breakthrough pain (P < 0.001) were independent risk factors of poor pain control in the 3-day treatment. These factors were also significantly associated with longer time needed to achieve stable pain control. Of the 185 patients treated with opioids, higher doses of analgesics were used in younger patients (<60 years old; P = 0.018), and in patients with severe pain (P < 0.001), neuropathic pain (P = 0.002), and frequent breakthrough pain (P = 0.015).
CONCLUSIONS: Factors associated with more difficult pain control include gastrointestinal tumor, severe baseline pain, presence of breakthrough pain, and neuropathic etiology of pain.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Advanced cancer; Analgesic effect; Chronic pain; Factors

Mesh:

Substances:

Year:  2018        PMID: 29934220     DOI: 10.1016/j.currproblcancer.2018.05.002

Source DB:  PubMed          Journal:  Curr Probl Cancer        ISSN: 0147-0272            Impact factor:   3.187


  6 in total

1.  Perceptions on the current content and pedagogical approaches used in end-of-life care education among undergraduate nursing students: a qualitative, descriptive study.

Authors:  Wenjing Cao; Chunyan Li; Qianqian Zhang; Huiru Tong
Journal:  BMC Med Educ       Date:  2022-07-16       Impact factor: 3.263

2.  The prognostic and predictive role of pain before systemic chemotherapy in recurrent ovarian cancer: an individual participant data meta-analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) of 1226 patients.

Authors:  H Woopen; R Richter; G Inci; S Alavi; R Chekerov; J Sehouli
Journal:  Support Care Cancer       Date:  2019-08-05       Impact factor: 3.603

3.  Barriers to cancer pain management from the perspective of patients: A qualitative study.

Authors:  Samira Orujlu; Hadi Hassankhani; Azad Rahmani; Zohreh Sanaat; Abbas Dadashzadeh; Atefeh Allahbakhshian
Journal:  Nurs Open       Date:  2021-10-17

4.  Retrospective Observational Study on the Characteristics of Pain and Associated Factors of Breakthrough Pain in Advanced Cancer Patients.

Authors:  Rongrong Fan; Xuying Li; Siyu Yang; Xiaofan Bu; Yongyi Chen; Ying Wang; Cuiling Qiu
Journal:  Pain Res Manag       Date:  2022-04-14       Impact factor: 2.667

5.  A multicentre survey of pain management in cancer patients and physicians attending radiotherapy clinics in Shandong Province, China.

Authors:  Bingxu Tan; Baosheng Li; Yongheng An; Xuezhen Ma; Yuhua Jiang; Yipeng Song; Xingping Ge; Shengli Yuan; Liping Liu; Yan Dou; Yanxia Yu; Pu Ji; Xia Li; Yufeng Cheng
Journal:  J Int Med Res       Date:  2019-10-06       Impact factor: 1.671

6.  Evaluating the stability of opioid efficacy over 12 months in patients with chronic noncancer pain who initially demonstrate benefit from extended release oxycodone or hydrocodone: harmonization of Food and Drug Administration patient-level drug safety study data.

Authors:  John T Farrar; Warren B Bilker; Philip T Cochetti; Charles E Argoff; Jennifer Haythornthwaite; Nathaniel P Katz; Ian Gilron
Journal:  Pain       Date:  2022-01-01       Impact factor: 6.961

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.